AurorA Science
Overview
AurorA Science is a biotech investment company that integrates a financial and industrial approach to support independent and entrepreneurial biotech start-ups with high therapeutic potential.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| InteRNA Technologies | Feb 2021 | Series B Extension | Lead |
| Peptomyc | Mar 2024 | VC Round | Lead |
Key People
Edoardo Negroni
Co-Founder and Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is AurorA Science based?
AurorA Science is headquartered in Milan, Italy.
When was AurorA Science founded?
AurorA Science was founded in 2020.
How many portfolio companies does AurorA Science have?
AurorA Science has 2 portfolio companies in Caplight's dataset.
What are some companies in AurorA Science's portfolio?
Portfolio companies visible on Caplight include InteRNA Technologies, Peptomyc.
What was AurorA Science's most recent investment shown here?
AurorA Science's most recent investment in this portfolio sample was in Peptomyc in 2024.
What sectors does AurorA Science focus on?
AurorA Science focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does AurorA Science focus on?
Stage focus information for AurorA Science is not publicly available.